ω-3PUFAs prevent MK-801-induced cognitive impairment in schizophrenic rats via the CREB/BDNF/TrkB pathway

Abstract

This study was to determine the protective effect of ω-3 polyunsaturated fatty acids (ω-3PUFAs) on MK-801-induced cognitive impairment in schizophrenia (SZ) rats and the underlying mechanism. A rat model of schizophrenia was induced by MK-801. The cognitive function of rats was assessed using a Morris water maze. The number of hippocampal neurons was measured by Nissl staining. The expression of CREB, p-CREB, BDNF, TrkB, p-TrkB, AKT, p-AKT, ERK, and p-ERK in the hippocampus of rats was detected by Western blotting. The results showed that ω-3PUFAs attenuated MK-801-induced cognitive impairment and hippocampal neurons loss, reversed the injury of the CREB/BDNF/TrkB pathway induced by MK-801, and antagonized MK-801-induced down-regulation of p-AKT and p-ERK in the hippocampus of rats. In conclusion, ω-3PUFAs enhances the CREB/BDNF/TrkB pathway by activating ERK and AKT, thereby increasing the synaptic plasticity and decreasing neuron loss, and antagonizing MK-801-induced cognitive impairment in schizophrenic rats.

Keywords

schizophrenia / MK-801 / ω-3 polyunsaturated fatty acids / cognition impairment / CREB/BDNF/TrkB pathway

References

[1] Gomez-PinillaF, TyagiE. Diet and cognition: interplay between cell metabolism and neuronal plasticity. Curr Opin Clin Nutr Metab Care, 2013, 16(6): 726-733 PMID: 24071781 PMCID: 4005410

[2] AndreevaVA, Kesse-GuyotE, Barberger-GateauP, et al. . Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. Am J Clin Nutr, 2011, 94(1): 278-286 PMID: 21593490

[3] EmsleyR, OosthuizenP, van RensburgSJ. Clinical potential of omega-3 fatty acids in the treatment of schizophrenia. CNS Drugs, 2003, 17(15): 1081-1091 PMID: 14661986

[4] Sarkadi-NagyE, WijendranV, DiauGY, et al. . Formula Feeding Potentiates Docosahexaenoic and Arachidonic Acid Biosynthesis in Term and Preterm Baboon Neonates. J Lipid Res, 2004, 45(1): 71-80 PMID: 14523049

[5] JohnsonI, Ben AzouzO, KebirO, et al. . Evaluation of correlations between cognitive performances and clinical dimensions of schizophrenia. Tunis Med, 2009, 87(10): 664-669 PMID: 20187354

[6] BilderRM, ReiterG, BatesJ, et al. . Cognitive development in schizophrenia: Follow-Back from the first episode. J Clin Exp Neuropsychol, 2006, 28(2): 270-282 PMID: 16484098

[7] IqbalK, AlonsoAD, GondalJA, et al. . Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach. J Neural Transm Suppl, 2000, 59: 213-222 PMID: 10961432

[8] HanRZ, HuJJ, WengYC, et al. . NMDA receptor antagonist MK-801 reduces neuronal damage and preserves learning and memory in a rat model of traumatic brain injury. Neurosci Bull, 2009, 25(6): 367-375 PMID: 19927173

[9] XuJ, RongS, XieB, et al. . Memory impairment in cognitively impaired aged rats associated with decreased hippocampal creb phosphorylation: reversal by procyanidins extracted from the lotus seedpod. J Gerontol A Biol Sci Med Sci, 2010, 65(9): 933-940 PMID: 20530246

[10] WilliamsCM, El MohsenMA, VauzourD, et al. . Blueberry-Induced Changes in Spatial Working Memory Correlate with Changes in Hippocampal Creb Phosphorylation and Brain-Derived Neurotrophic Factor (Bdnf) Levels. Free Radic Biol Med, 2008, 45(3): 295-305 PMID: 18457678

[11] BekinschteinP, CammarotaM, IzquierdoI, et al. . BDNF and memory formation and storage. Neuroscientist, 2008, 14(2): 147-156 PMID: 17911219

[12] CarlezonW J, DumanRS, NestlerEJ. The many faces of Creb. Trends Neurosci, 2005, 28(8): 436-445 PMID: 15982754